Crawford R, Bell T, Rushton R, Doward L. A critique of YouTube™ as a data source for the qualitative exploration of patient-reported information on acute myeloid leukemia. Poster presented at the 2018 ISPOR 21st Annual European Congress; November 13, 2018. Barcelona, Spain.
Wolowacz SE, Briggs A, Doward L, Lloyd A. Collecting health-state utility estimates for economic models in clinical studies. Presented at the 2018 ISPOR 21st Annual European Congress; November 10, 2018. Barcelona, Spain.
Briggs A, Lloyd A, Doward L. Collecting health-state utility estimates for economic models in clinical studies. Presented at the 2018 ISPOR 23rd Annual International Meeting; May 19, 2018. Baltimore, MD. Previously presented at the ISPOR 19th Annual European Congress.
Doward L, Balp MM, Twiss J, Slota C, Cryer D, Langford A, Collen R, Agashivala N, Brass C, Anstee QM, Sanyal A. Measuring what matters to patients: the development of the NASH-CHECK, a new patient-reported outcome instrument for nonalcoholic steatohepatitis. Poster presented at the 2018 EASL International Liver Conference; April 13, 2018. Paris, France. [abstract] J Hepatol. 2018 Apr; 68(Suppl 1):S570.
Wolowacz S, Briggs A, Lloyd AJ, Doward L. Collecting health-state utility estimates for economic models in clinical studies. Presented at the 2016 ISPOR 19th Annual European Congress; October 29, 2016. Vienna, Austria.
Wolowacz SE, Briggs A, Belozeroff V, Clarke P, Doward L, Goeree R, Lloyd A, Norman R. Estimating health-state utility for economic models in clinical studies: an ISPOR good research practices task force report. Value Health. 2016 Sep;19(2016):704-19. doi: 10.1016/j.jval.2016.06.001
McKenna SP, Koppeschaar HPF, Zelissen PMJ, Snel YEM, Whalley D, Doward LC. The impact of replacement gh on the quality of life of patients: results of a clinical trial in the Netherlands. Poster presented at the 22nd International Symposium on Growth Hormone and Growth Factors in Endocrinology and Metabolism; October 18, 1996. Vienna, Austria.
McKenna S, Doward LC. Measuring quality of life in adults with growth hormone deficiency. Clin Endocrinol (Oxf). 1996 Oct;45(4):507-8.
McKenna SP, Doward LC. Quality-of-life assessment of adults with growth hormone deficiency: implications for drug therapy. Pharmacoeconomics. 1994 Nov 1;6(5):434-41.
Doward LC. Developing a measure of quality of life for patients with recurrent genital herpes. Drug Inf J. 1994 Jan 1;28(1):19-25.